Loại tài liệu:    Chỉ tìm trong: 
431-440 trong số 512 kết quả
Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin
Tác giả: John S Wang, Jack C Shapiro, Sarah Orlando, Rusul Al-Marayaty, Farres Obeidin, David VanderWeele, Haris Charalambous, Seth M Pollack, Pedro Hermida de Viveiros
Xuất bản: Germany: Journal of cancer research and clinical oncology , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 
Retraction Note: Genetic inference and single cell expression analysis of potential targets in heart failure and breast cancer
Tác giả: Yue Li, Ying Huang, Ning An, Xiaomiao Guan, Bing Liu, Huiying Li, Tingting Jiang
Xuất bản: Germany: Journal of cancer research and clinical oncology , 2025
Bộ sưu tập: NCBI
ddc:  025.7
 
Drivers of centrosome abnormalities: senescence progression and tumor immune escape
Tác giả: Tao Jiang, Hua Jin, Xintong Ji, Xi Zheng, Cheng-Xiong Xu, Peng-Jun Zhang
Xuất bản: England: Seminars in cancer biology , 2025
Bộ sưu tập: NCBI
ddc:  972.8202
 
Characterization of canine tumor-infiltrating leukocyte transcriptomic signatures reveals conserved expression patterns ...
Tác giả: Dylan T Ammons, R Adam Harris, Lyndah Chow, Steven Dow
Xuất bản: Germany: Cancer immunology, immunotherapy : CII , 2025
Bộ sưu tập: NCBI
ddc:  636.0885
 
TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse...
Tác giả: Anna D Louie, Kelsey E Huntington, Young Lee, Jared Mompoint, Laura Jinxuan Wu, Seulki Lee, Thomas J Miner, Wafik S El-Deiry
Xuất bản: United States: American journal of cancer research , 2025
Bộ sưu tập: NCBI
ddc:  627.12
 
Five-year efficacy and safety of pembrolizumab as first-line treatment in patients with non-small cell lung cancer with PD-L1 tumor proportion score ≥50 %: A multicenter observational study
Tác giả: Yuichi Tambo, Takashi Sone, Shigeki Nanjo, Hayato Koba, Nanao Terada, Tsukasa Ueda, Shunichi Nomura, Yuya Murase, Seiji Yano, Koichi Nishi, Kazuhiko Shibata, Toshiyuki Kita, Tomoyuki Araya, Hiroki Shirasaki, Takahiro Shimizu, Taro Yoneda, Hiroki Matsuoka
Xuất bản: Ireland: Lung cancer (Amsterdam, Netherlands , 2025
Bộ sưu tập: NCBI
ddc:  306.877
 
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195
Tác giả: Jessica R Bauman, Geoffrey Liu, Martin Rupp, Jessica J Lin, Isabel Preeshagul, Stephen V Liu, Barbara Melosky, Devin Abrahami, Benjamin Li, Despina Thomaidou, Kirsten Duncan, Stan Krulewicz
Xuất bản: Ireland: Lung cancer (Amsterdam, Netherlands , 2025
Bộ sưu tập: NCBI
ddc:  546.677
 
Eosinophil-induced adverse events induced by treatment with programmed cell death 1/ligand 1 inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
Tác giả: Lu Lyu, Sainan Bian, Kai Guan, Bin Zhao
Xuất bản: United States: International journal of cancer , 2025
Bộ sưu tập: NCBI
ddc:  904.7
 
Evaluation of Neutrophil Activation Biomarkers in Response to Programmed Cell Death Protein-1 (PD-1) and Toll-like Receptor 9 (TLR-9) Inhibition in Triple Negative Breast Cancer
Tác giả: Sara Youssry, Amina Hussein, Nadia Abd El Moneim, Alaa Samy, Asmaa Mostafa, Mohamed H Sultan
Xuất bản: United States: Clinical breast cancer , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 
Corrigendum to "Real-world comparative effectiveness of sotorasib versus docetaxel in second line and beyond among patients with advanced non-small cell lung cancer (NSCLC)" [Lung Cancer 197 (2024
Tác giả: Melissa Johnson, Diana Younan, Shia T Kent, Marco Mesa Frias, M Alan Brookhart, Akhila Balasubramanian, Alexander Spira
Xuất bản: Ireland: Lung cancer (Amsterdam, Netherlands , 2025
Bộ sưu tập: NCBI
ddc:  546.677
 

Truy cập nhanh danh mục